The Senate Health, Education, Labor, and Pensions Committee recently conducted a hearing to evaluate the 340B Drug Pricing Program. The session focused on the program's expansion and its impact on patients. The American Hospital Association (AHA) expressed support for the program, highlighting its importance in reducing drug costs and compensating for chronic underpayments from Medicare and Medicaid.
The AHA emphasized the program's critical role in supporting rural communities. They said, "Most rural hospitals lose money when providing critical medical services needed in their communities and therefore rely on 340B savings to remain operational and provide specialty care." The association cautioned that without these services, rural patients might face long-distance travel for similar care, which could be impractical for many.
For further details about the Senate Committee's activities, visit their official website at https://www.help.senate.gov/.
Information from this article can be found here.
